Claret Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Claret Asset Management's AMGN Position: Q2 2026 in Review
Claret Asset Management reduced its Amgen (AMGN) stake by 0.12% in Q2 2026, selling an estimated $2.05K and leaving 4,880 shares worth $1.77M. The position accounts for 0.19% of the portfolio, ranked #62.
Claret Asset Management first reported a position in AMGN in Q4 2017 and has held it in 22 quarters since. 3,150 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Claret Asset Management held 4,880 shares of Amgen worth $1.77M as of Q2 2026.
- Claret Asset Management sold 6 Amgen shares in Q2 2026, an estimated $2.05K.
- Amgen made up 0.19% of Claret Asset Management's portfolio in Q2 2026, its #62 holding.
- Claret Asset Management first reported a position in Amgen in Q4 2017 and has held it in 22 quarters since.
- 3,150 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.